Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Weight Loss/Management

Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study

O'Donnell C, Crilly S, O'Mahony A, O'Riordan B, Traynor M, Gitau R, McDonald K, Ledwidge M, O'Shea D, Murphy DJ, Dodd JD, Ryan S. Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study Ann Am Thorac Soc

The emergence of obesity in type 1 diabetes

Kueh MTW, Chew NWS, Al-Ozairi E, le Roux CW. The emergence of obesity in type 1 diabetes Int J Obes (Lond)
Insulin Resistance & Diabetes

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

Bindlish S, Ng J, Ghusn W, Fitch A, Bays HE. Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023 Obes Pillars

Mothers’ experiences of a lifestyle intervention for weight reduction 12 months after gestational diabetes mellitus: Qualitative findings from the PAIGE2 study

Kemp BJ, Creighton RM, Cupples G, Kelly B, McAuley E, Fleck O, Wallace H, Graham U, McCance DR. Mothers’ experiences of a lifestyle intervention for weight reduction 12 months after gestational diabetes mellitus: Qualitative findings from the PAIGE2 study Midwifery
Insulin Resistance & Diabetes

The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma

Nanzer AM, Taylor V, Hearn AP, Kavanagh JE, Patrick T, Green L, Thomson L, Lam J, Fernandes M, Roxas C, d'Ancona G, Kent BD, Dhariwal J, Jackson DJ. The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma Eur Respir J

Diet-induced Weight Loss and Phenotypic Flexibility Among Healthy Overweight Adults: A Randomized Trial

Rundle M, Fiamoncini J, Thomas EL, Wopereis S, Afman LA, Brennan L, Drevon CA, Gundersen TE, Daniel H, Perez IG, Posma JM, Ivanova DG, Bell JD, van Ommen B, Frost G. Diet-induced Weight Loss and Phenotypic Flexibility Among Healthy Overweight Adults: A Randomized Trial Am J Clin Nutr

Increased Lean Body Mass After Bodyweight-Based High Intensity Interval Training in Overweight and Obese Men

Timmons JF, Beatty A, Stout C, Ivory A, Carroll C, Egan B. Increased Lean Body Mass After Bodyweight-Based High Intensity Interval Training in Overweight and Obese Men Res Q Exerc Sport

The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets: A Report from the 23rd Annual Harvard Nutrition Obesity Symposium

Becetti I, Bwenyi EL, de Araujo IE, Ard J, Cryan JF, Farooqi IS, Ferrario CR, Gluck ME, Holsen LM, Kenny PJ, Lawson EA, Lowell BB, Schur EA, Stanley TL, Tavakkoli A, Grinspoon SK, Singhal V. The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets: A Report from the 23rd Annual Harvard Nutrition Obesity Symposium Am J Clin Nutr

Weight loss to disrupt type 2 diabetes

Alsaqaaby MS, le Roux CW. Weight loss to disrupt type 2 diabetes Diabetol Int
Insulin Resistance & Diabetes

The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma

Nanzer AM, Taylor V, Hearn AP, Kavanagh JE, Patrick T, Green L, Thomson L, Lam J, Fernandes M, Roxas C, d'Ancona G, Kent BD, Dhariwal J, Jackson DJ. The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma Eur Respir

Older posts

Newer posts

← Previous Page1 Page2 Page3 Page4 … Page20 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI